Braster S.A. Total Assets
Braster S.A. total assets. Based on the latest financial reports, Braster S.A. (BRA) holds total assets worth zł18.64 Million PLN (≈ $5.13 Million USD) as of March 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BRA company net worth for the company's overall valuation and market capitalisation.
Total Assets of Braster S.A. (2011–2023)
Total assets of Braster S.A. from 2011 to 2023. This chart illustrates how Braster S.A.'s total assets have evolved over time, based on quarterly financial data. See Braster S.A. share price for real-time trading data and today's change.
Braster S.A. - Asset Composition Analysis
Braster S.A. Total Assets Breakdown (December 2023)
Braster S.A. total assets breakdown as of December 2023. Braster S.A.'s total assets of zł18.64 Million consist of 56.1% current assets and 43.9% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 0.1% |
| Accounts Receivable | zł353.00K | 1.9% |
| Inventory | zł4.64 Million | 24.3% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł714.00K | 3.7% |
| Goodwill | zł0.00 | 0.0% |
Asset Composition Trend (2011–2023)
This chart illustrates how Braster S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BRA working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Braster S.A.'s current assets represent 56.1% of total assets in 2023, an increase from 15.4% in 2011.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2023, down from 4.8% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 48.0% in 2011.
- Asset Diversification: The largest asset category is inventory at 24.3% of total assets.
Braster S.A. Competitors by Total Assets
Key competitors of Braster S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Braster S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.52 | 0.34 | 0.99 |
| Quick Ratio | 0.29 | 0.04 | 0.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł-9.49 Million | zł-10.67 Million | zł-103.00K |
Braster S.A. - Advanced Valuation Insights
This section examines the relationship between Braster S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.76 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | -21.3% |
| Total Assets | zł19.12 Million |
| Market Capitalization | $4.69 Million USD |
Valuation Analysis
Below Book Valuation: The market values Braster S.A.'s assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Braster S.A.'s assets decreased by 21.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Braster S.A. (2011–2023)
The table below shows the annual total assets of Braster S.A. from 2011 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | zł19.12 Million ≈ $5.26 Million |
-21.34% |
| 2022-12-31 | zł24.30 Million ≈ $6.69 Million |
+2.38% |
| 2021-12-31 | zł23.74 Million ≈ $6.53 Million |
-33.84% |
| 2020-12-31 | zł35.88 Million ≈ $9.87 Million |
-26.58% |
| 2019-12-31 | zł48.87 Million ≈ $13.45 Million |
-10.38% |
| 2018-12-31 | zł54.53 Million ≈ $15.01 Million |
-25.92% |
| 2017-12-31 | zł73.61 Million ≈ $20.26 Million |
+13.53% |
| 2016-12-31 | zł64.83 Million ≈ $17.84 Million |
+36.02% |
| 2015-12-31 | zł47.67 Million ≈ $13.12 Million |
+249.90% |
| 2014-12-31 | zł13.62 Million ≈ $3.75 Million |
+114.46% |
| 2013-12-31 | zł6.35 Million ≈ $1.75 Million |
-29.31% |
| 2012-12-31 | zł8.99 Million ≈ $2.47 Million |
+1082.21% |
| 2011-12-31 | zł760.13K ≈ $209.20K |
-- |
About Braster S.A.
Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination… Read more